Hot Features
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension ... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.0002 | 0.0002 | 0.0002 | 62575 | 0.0002 | CS |
| 12 | 0 | 0 | 0.0002 | 0.0002 | 0.0002 | 38618 | 0.0002 | CS |
| 26 | 0.0001 | 100 | 0.0001 | 0.0002 | 0.0001 | 27236 | 0.00019513 | CS |
| 52 | 0.0001 | 100 | 0.0001 | 0.0002 | 0.0001 | 53320 | 0.0001216 | CS |
| 156 | -0.0003 | -60 | 0.0005 | 0.0006 | 1.0E-6 | 34068 | 0.00012469 | CS |
| 260 | 0.0001 | 100 | 0.0001 | 0.0062 | 1.0E-6 | 52463 | 0.00231832 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.